Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study
ConclusionFindings from this study demonstrate that the efficacy of etelcalcetide is maintained over the long term.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Dialysis | Hemodialysis | Hyperparathyroidism | Renal Failure | Sensipar | Study | Urology & Nephrology | Vitamin D | Vitamins